Lung Function Responder Rates in the Voyage Study in Children with Moderate-to-severe Type 2 Asthma Receiving Dupilumab

被引：0
|
作者：
Guilbert, T. W. [1 ,2 ]
Fiocchi, A. G. [3 ]
Murphy, K. R. [4 ]
Hamelmann, E. [5 ]
Ross, K. [6 ]
Gupta, A. [7 ]
Xia, C. [8 ]
Gall, R. [8 ]
Ledanois, O. [9 ]
Radwan, A. [8 ]
Jacob-Nara, J. A. [10 ]
Rowe, P. J. [10 ]
Deniz, Y. [8 ]
机构：
[1] Cincinnati Childrens Hosp, Cincinnati, OH USA
[2] Univ Cincinnati, Cincinnati, OH USA
[3] Bambino Gesu Childrens Hosp IRCCS, Rome, Italy
[4] Boys Town Natl Res Hosp, Boys Town, NE USA
[5] Univ Bielefeld, Bielefeld, Germany
[6] Case Western Reserve Univ, Cleveland, OH USA
[7] Kings Coll Hosp London, London, England
[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[9] Sanofi, Paris, France
[10] Sanofi, Bridgewater, France
来源：
PEDIATRIC PULMONOLOGY | 2023年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
A 10
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [41] Dupilumab Reduces Exacerbations And Improves Lung Function In Children (6-11 Years) With Moderate-To-Severe Asthma And High Eosinophils
    Jackson, Daniel
    Hamelmann, Eckard
    Roberts, Graham
    Bacharier, Leonard
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Jacob-Nara, Juby
    Radwan, Amr
    Rowe, Paul
    Deniz, Yamo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB194 - AB194
  • [42] Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion
    Bacharier, L. B.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A. G.
    Gagnon, R.
    de Mir, I.
    Guilbert, T. W.
    Jackson, D. J.
    Li, N.
    Akinlade, B.
    Laws, E.
    Mannent, L. P.
    Maloney, J.
    Tawo, K.
    Khokhar, F. A.
    Hardin, M.
    Abdulai, R. M.
    Lederer, D. J.
    Robinson, L. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [43] DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY
    Maspero, Jorge
    Fitzgerald, Mark
    Pavord, Ian
    Wenzel, Sally
    Zhang, Bingzhi
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil
    Teper, Ariel
    CHEST, 2018, 154 (04) : 25A - 27A
  • [44] Dupilumab efficacy in children with uncontrolled, moderate-to-severe asthma with and without an allergic phenotype
    Papadopoulos, Nikolaos
    Szefler, Stanley J.
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Domingo, Christian
    Daizadeh, Nadia
    Lederer, David J.
    Hardin, Megan
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Gall, Rebecca
    Ortiz, Benjamin
    Djandji, Michel
    Rowe, Paul
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [45] Dupilumab Induces Clinical Remission in Patients With Uncontrolled, Moderate-to-Severe, Type 2 Inflammatory Asthma
    Pavord, I. D.
    Israel, E.
    Szefler, S. J.
    Brusselle, G.
    Rabe, K. F.
    Chen, Z.
    Altincatal, A.
    Radwan, A.
    Pandit-Abid, N.
    Amin, N.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y. M.
    Khan, A.
    Lederer, D. J.
    Zhang, Y.
    Busse, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [46] Dupilumab Efficacy in Patients with Moderate-to-Severe Type 2 Asthma With and Without Elevated Blood Neutrophils
    Bleecker, E. R.
    Panettieri, R. A.
    Lugogo, N. L.
    Corren, J.
    Daizadeh, N.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Khodzhayev, A.
    Ortiz, B.
    Ferro, T. J.
    Hansen, C. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [47] Dupilumab Treatment Leads to Clinical Asthma Remission in Patients With Uncontrolled Moderate-to-Severe Asthma With Type 2 Inflammation
    Pavord, Ian
    Busse, William
    Israel, Elliot
    Szefler, Stanley
    Chen, Zhen
    Daizadeh, Nadia
    Lederer, David
    Mannent, Leda
    Amin, Nikhil
    Laws, Elizabeth
    Ruddy, Marcella
    Rowe, Paul
    Deniz, Yamo
    Khan, Asif
    Zhang, Yi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB4 - AB4
  • [48] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [49] Long-Term Dupilumab Treatment in Moderate-to-Severe Asthma with Type 2 Inflammation: Open Label LIBERTY ASTHMA TRAVERSE Study
    Wechsler, M.
    Pavord, I. D.
    Papi, A.
    Chapman, K. R.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Ruddy, M. K.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [50] Dupilumab treatment induces clinical remission in patients with uncontrolled, moderate-to-severe, type 2 inflammatory asthma
    Pavord, I.
    Pandit-Abid, N.
    Israel, E.
    Szefler, S.
    Brusselle, G.
    Rabe, K.
    Chen, Z.
    Altincatal, A.
    Amin, N.
    Khan, A.
    Lederer, D. H.
    Zhang, Y.
    Rowe, P. J.
    Deniz, Y.
    Amr, R.
    Jacob-Nara, J. A.
    Busse, W. W.
    ALLERGY, 2023, 78 : 206 - 207
12345